HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hilde Rosing Selected Research

Bendamustine Hydrochloride

3/2013Pharmacokinetics and excretion of 14C-bendamustine in patients with relapsed or refractory malignancy.
7/2012Metabolite profiling of bendamustine in urine of cancer patients after administration of [14C]bendamustine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hilde Rosing Research Topics

Disease

63Neoplasms (Cancer)
05/2024 - 01/2002
24Breast Neoplasms (Breast Cancer)
01/2022 - 11/2002
10Prostatic Neoplasms (Prostate Cancer)
10/2023 - 10/2015
5Melanoma (Melanoma, Malignant)
05/2024 - 01/2014
5Diarrhea
03/2024 - 11/2019
5Nausea
06/2023 - 07/2009
5Sarcoma (Soft Tissue Sarcoma)
11/2021 - 05/2007
5Renal Cell Carcinoma (Grawitz Tumor)
05/2020 - 01/2012
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 04/2004
3Vomiting
06/2023 - 07/2009
3Visceral Leishmaniasis (Kala Azar)
11/2022 - 01/2022
3Leishmaniasis
11/2022 - 01/2022
3Neutropenia
01/2022 - 05/2002
3Brain Neoplasms (Brain Tumor)
01/2022 - 01/2019
3Dihydropyrimidine Dehydrogenase Deficiency
01/2022 - 07/2016
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2020
3Hematologic Neoplasms (Hematological Malignancy)
03/2019 - 03/2013
3Ovarian Neoplasms (Ovarian Cancer)
04/2008 - 02/2003
2Body Weight (Weight, Body)
08/2023 - 05/2002
2Inflammation (Inflammations)
08/2023 - 02/2023
2Neglected Diseases
11/2022 - 08/2022
2Exanthema (Rash)
01/2020 - 01/2020
2Neoplasm Metastasis (Metastasis)
06/2018 - 10/2015
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2016 - 10/2016
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016 - 03/2014
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
03/2014 - 06/2012
1Malaria
04/2024
1Enteritis
11/2023
1Failure to Thrive
11/2023
1Glucose Intolerance
08/2023
1Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2023
1Insulin Resistance
08/2023

Drug/Important Bio-Agent (IBA)

12Docetaxel (Taxotere)FDA Link
03/2024 - 02/2003
10Proteins (Proteins, Gene)FDA Link
05/2020 - 11/2002
8Member 1 Subfamily B ATP Binding Cassette TransporterIBA
05/2020 - 10/2004
6Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 04/2004
5Cytochrome P-450 CYP3AIBA
10/2023 - 09/2013
5TamoxifenFDA LinkGeneric
10/2021 - 06/2011
5Capecitabine (Xeloda)FDA Link
05/2020 - 04/2010
5Tyrosine Kinase InhibitorsIBA
01/2020 - 01/2012
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2024 - 01/2020
4Abiraterone AcetateIBA
10/2023 - 06/2019
4UracilIBA
01/2023 - 07/2016
4pazopanibFDA Link
11/2021 - 01/2016
4Imatinib Mesylate (Gleevec)FDA Link
08/2020 - 04/2009
4Fluorouracil (Carac)FDA LinkGeneric
05/2020 - 04/2010
4ElacridarIBA
10/2015 - 10/2004
4TrabectedinIBA
12/2009 - 01/2002
3Monoclonal AntibodiesIBA
10/2023 - 08/2009
3Hormones (Hormone)IBA
01/2022 - 06/2019
3Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2022 - 10/2020
3Ritonavir (Norvir)FDA Link
01/2021 - 06/2009
3enzalutamideIBA
12/2019 - 01/2019
3taxaneIBA
10/2015 - 04/2004
2VorinostatFDA Link
05/2024 - 04/2020
2LipidsIBA
08/2023 - 02/2023
2Aprepitant (Emend)FDA Link
06/2023 - 12/2022
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2022 - 01/2014
2abemaciclibIBA
01/2022 - 09/2021
2Biomarkers (Surrogate Marker)IBA
10/2021 - 04/2006
2abirateroneIBA
01/2021 - 10/2019
2Cisplatin (Platino)FDA LinkGeneric
01/2021 - 09/2017
2guadecitabineIBA
01/2020 - 03/2019
25'-deoxy-5-fluorocytidineIBA
12/2019 - 04/2010
2AndrogensIBA
12/2019 - 06/2019
2doxifluridineIBA
12/2019 - 04/2010
2DNA (Deoxyribonucleic Acid)IBA
11/2019 - 07/2009
2dihydrouracilIBA
06/2018 - 07/2016
2Carboplatin (JM8)FDA LinkGeneric
09/2017 - 07/2009
2PlatinumIBA
09/2017 - 05/2002
24-hydroxy-N-desmethyltamoxifenIBA
01/2017 - 06/2011
2HomoharringtonineIBA
12/2016 - 10/2016
2VemurafenibIBA
10/2016 - 01/2014
2Bendamustine HydrochlorideFDA Link
03/2013 - 07/2012
2Trastuzumab (Herceptin)FDA Link
01/2013 - 08/2009
2NucleosidesIBA
06/2012 - 03/2011
2Topotecan (Hycamtin)FDA LinkGeneric
07/2009 - 05/2002
2GemcitabineFDA Link
06/2008 - 01/2007
2Antineoplastic Agents (Antineoplastics)IBA
01/2007 - 09/2002
2N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA
08/2005 - 09/2002
1Histone Deacetylase InhibitorsIBA
05/2024
1ArtesunateIBA
04/2024
1pyronaridineIBA
04/2024
1IpilimumabIBA
04/2024
1Loperamide (Imodium)FDA LinkGeneric
03/2024
1pembrolizumabIBA
11/2023
1Immune Checkpoint InhibitorsIBA
11/2023
1Mixed Function Oxygenases (Monooxygenases)IBA
10/2023
1Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA
10/2023
1Midazolam (Versed)FDA LinkGeneric
10/2023
1NivolumabIBA
10/2023
1Carboxylic Ester HydrolasesIBA
08/2023

Therapy/Procedure

10Therapeutics
10/2021 - 06/2008
7Castration
10/2023 - 01/2019
6Drug Therapy (Chemotherapy)
06/2023 - 02/2003
4Intravenous Administration
03/2024 - 05/2007
3Oral Administration
10/2023 - 06/2008
2Radiotherapy
11/2021 - 11/2018
2Renal Dialysis (Hemodialysis)
01/2019 - 01/2016
2Cytoreduction Surgical Procedures
04/2008 - 02/2003